Tardive dyskinesia causes involuntary movements in some people taking antipsychotic medications. Here’s what you need to know about this movement disorder. Antipsychotic medications are a mainstay of ...

—These investigators examined more than 2 decades’ worth of de-identified electronic health records to learn more about why tardive dyskinesia is likely to be underreported and misdiagnosed in routine ...

Tardive dyskinesia (TD) is a movement disorder linked to neuroleptics, a type of antipsychotic drug. Some studies suggest 20 to 50% of people taking neuroleptics develop TD during treatment, and it ...

While any patients taking an anti-dopaminergic agent may develop tardive dyskinesia (TD) -- a movement disorder hallmarked by abnormal and involuntary tics of the face, trunk, and limbs -- older ...

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify iwaters@healio.com if there are concerns regarding accuracy of the transcription ...

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify iwaters@healio.com if there are concerns regarding accuracy of the transcription ...

Kristin Weiland is a documentary film producer and writer with a background in crisis management and ethnographic research. She specializes in investigative and social impact documentary projects, and ...

Study reveals over half of long-term care residents with tardive dyskinesia do not receive standard treatment, highlighting care gaps. Less than half of patients diagnosed with tardive dyskinesia in ...

SOLANA BEACH, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) disorders with an ...

Evoke Pharma, Inc. announced that an abstract comparing the incidence of tardive dyskinesia (TD) in patients undergoing continuous versus intermittent oral metoclopramide treatment has been accepted ...